A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance
Lequn Li(Beth Israel Deaconess Medical Center), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Yoshiko Iwamoto(Harvard University), Alla Berezovskaya(Ontario Institute for Cancer Research)
Cited by 89
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
|Nature Medicine|2013|1k